Morgan Stanley
QNRX

Morgan Stanley’s Quoin Pharmaceuticals QNRX Stock Holding History

Morgan Stanley’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4K Buy
4,000
+1,000
+33% +$9.06K ﹤0.01% 6634
2025
Q4 		$43.3K Buy
+3,000
New +$40.8K ﹤0.01% 6482
2025
Q3 		– Sell
-206
Closed -$1.9K – 8328
2025
Q2 		$1.9K Buy
206
+193
+1,485% +$1.48K ﹤0.01% 7233
2025
Q1 		$102 Buy
+13
New +$171 ﹤0.01% 7567
2023
Q1 		– Hold
0
– -$111 – 7807
2022
Q4 		– Hold
0
– – – 7688
2022
Q3 		– Hold
0
– – – 7840
2022
Q1 		– Sell
-21
Closed -$198K – 8085
2021
Q4 		$198K Buy
+21
New +$903K ﹤0.01% 6080
2021
Q3 		– Hold
0
– – – 7057
2021
Q2 		– Hold
0
– – – 7011
2021
Q1 		– Hold
0
– – – 6804
2020
Q4 		– Hold
0
– – – 6407
2020
Q3 		– Hold
0
– – – 6030
2020
Q2 		– Hold
0
– – – 5951
2019
Q4 		– Hold
0
– – – 6740
2019
Q3 		– Hold
0
– – – 6729
2019
Q2 		– Hold
0
– – – 6720
2019
Q1 		– Hold
0
– – – 6038
2018
Q4 		– Hold
0
– – – 5895
2018
Q3 		– Hold
0
– – – 5788
2018
Q2 		– Hold
0
– – – 5690
2018
Q1 		– Hold
0
– – – 5719
2017
Q4 		– Hold
0
– – – 5740
2017
Q3 		– Hold
0
– – – 5642
2017
Q2 		– Hold
0
– – – 5718
2017
Q1 		– Hold
0
– – – 5655

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Morgan Stanley's QNRX Position: Q1 2026 in Review

Morgan Stanley increased its Quoin Pharmaceuticals (QNRX) stake by 33% in Q1 2026, buying an estimated $9.06K and bringing the position to 4,000 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6634.

Morgan Stanley first reported a position in QNRX in Q4 2021 and has held it in 5 quarters since. The position peaked at $198K in Q4 2021. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Morgan Stanley held 4,000 shares of Quoin Pharmaceuticals worth $26.4K as of Q1 2026.
  • Morgan Stanley bought 1,000 Quoin Pharmaceuticals shares in Q1 2026, an estimated $9.06K.
  • Quoin Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6634 holding.
  • Morgan Stanley first reported a position in Quoin Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
  • Morgan Stanley's Quoin Pharmaceuticals position peaked at $198K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.